Metagenomi Posts Q4 $0.60 Loss and 54.8% Revenue Shortfall
Metagenomi reported Q4 loss of $0.60 per share versus a projected $0.58 loss and missed revenue at $3.91 million, down 59% from $9.61 million a year earlier. The company posted a 2025 loss of $2.36 per share on $25.2 million revenue and projects Q1 EPS of -$0.50 on $8.66 million.
1. Q4 Financial Results
Metagenomi reported a Q4 loss of $0.60 per share, missing the consensus estimate by $0.02 and registering an earnings surprise of -4.35%. Revenue for the quarter reached $3.91 million, down 59% from $9.61 million a year earlier and 54.8% below analyst estimates.
2. Outlook and Projections
For fiscal 2025, the company recorded a loss of $2.36 per share on $25.2 million in revenue. Management forecasts Q1 EPS of -$0.50 on $8.66 million in sales and a full-year 2026 EPS of -$1.71 on $25.42 million in revenue, while shares have declined 1.2% year-to-date.